Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies

BACKGROUND AND AIMS: Many patients with coronavirus disease 2019 (COVID-19) have comorbidities related to metabolic syndrome (MS) during the disease course. Its presence in different ethnicities and continents places MS as an important risk factor for COVID-19. Adequate understanding of the interpla...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Fernanda Farias, Rosário, Wilian Reis, Ribeiro Farias, Ana Cláudia, de Souza, Ramon Guimarães, Duarte Gondim, Roberta Sabrine, Barroso, Wermerson Assunção
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286828/
https://www.ncbi.nlm.nih.gov/pubmed/32540733
http://dx.doi.org/10.1016/j.dsx.2020.06.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286828/
https://www.ncbi.nlm.nih.gov/pubmed/32540733
http://dx.doi.org/10.1016/j.dsx.2020.06.016

Ejemplares similares